Abstract
We examined and compared the effects of levosimendan, a new myofilament calcium sensitizer with phosphodiesterase inhibiting activity, pimobendan, and milrinone on left ventricular-arterial coupling and mechanical efficiency in 21 experiments performed in open-chest, barbiturate-anesthetized dogs instrumented for measurement of aortic and left ventricular (LV) pressure (micromanometer-tipped catheter), +dP/dt, and LV volume (conductance catheter). Myocardial contractility was assessed with the endsystolic pressure-volume relation (Ees) and preload recruitable stroke work (Msw) generated from a series of differentially loaded LV pressurevolume diagrams. LV-arterial coupling and mechanical efficiency were determined by the ratio of Ees to effective arterial elastance (Ea; the ratio of end-systolic arterial pressure to stroke volume) and the ratio of stroke work (SW) to pressure-volume area (PVA), respectively. Levosimendan (0.75, 1.5, and 3.0 μg·kg−1·min−1) significantly (p<0.05) increased heart rate, +dP/dt, and ejection fraction (EF) and decreased mean arterial pressure (MAP), pressurework index (PWI; an estimate of myocardial oxygen consumption), and LV systolic and end-diastolic pressures (LVSP and LVEDP) and volumes (EDV and ESV). Levosimendan-induced augmentation of myocardial contractility (Ees, Msw, and+dP/dt) and reductions in LV afterload (Ea) caused increases in the Ees/Ea ratio (0.61±0.10 during control to 3.3±0.7 during the high dose) consistent with enhancement of LV-arterial coupling. Levosimendan increased SW/PVA (0.48±0.05 during control to 0.84±0.04 during the high dose), indicating this drug improves the transfer of myocardial potential energy to external work. Levosimendan also increased the ratio of SW to PWI (109±18 during control to 255±50 mmHg·min·100g during the high dose), suggesting that myocardial metabolic efficiency was improved as well. Like levosimendan, pimobendan and milrinone (10, 20, and 40 and 1.0, 2.0, and 4.0 μg·kg−1·min−1, respectively) increased HR, +dP/dt, EF, Ees, and Msw and decreased MAP, LVSP, LVEDP, EDV, ESV, and Ea. In contrast to levosimendan, neither agent reduced PWI. Pimobendan and milrinone caused dose-related increases in Ees/Ea, SW/PVA, and SW/PWI. The results indicate that levosimendan, pimobendan, and milrinone augment myocardial contractility, produce venous and arteriolar vasodilation, and enhance LV-arterial coupling and mechanical efficiency in open-chest, barbiturateanesthetized dogs.
Similar content being viewed by others
References
Applegate RJ, Cheng C-P, Little WC (1990) Simultaneous conductance catheter and dimension assessment of left ventricle volume in the intact animal. Circulation 81: 638–648
Applegate RJ, Little WC (1994) Alteration of autonomic influence on left ventricular contractility by epicardial superfusion with hexamethonium and procaine. Cardiovasc Res 28: 1042–1048
Baan, J, Jong TT, Kerkhof PLM, Moene RJ, Van Dijk AD, Van der Velde ET, Koops J (1981) Continuous stroke volume and cardiac output from intraventricular dimensions obtained with impedance catheter. Cardiovasc Res 15: 328–334
Baan J, Van der Velde ET, De Bruin HG, Smeenk GJ, Koops J, van Dijk AD, Temmerman D, Senden J, Buis B (1984) Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 70: 812–823
Baumann G, Ningel K, Permanetter B (1989) Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy J Cardiovasc Pharmacol 13: 730–738
Bohm M, Morano I, Pieske B, Ruegg JC, Wankerl M, Zimmermann R, Erdmann E (1991) Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. Circ Res 68: 689–701
Boltwood Jr CM, Appleyard RF, Glantz SA (1989) Left ventricular volume measurement by conductance catheter in intact dogs. Parallel conductance volume depends on left ventricular size. Circulation 80: 1360–1377
Burkhoff D (1990) The conductance method of left ventricular volume estimation. Methodologic limitations put into perspective. Circulation 81: 703–706
Burkhoff D, Sagawa K (1986) Ventricular efficiency predicted by an analytical model. Am J Physiol 250: R1021-R1027
Burkhoff D, Sugiura S, Yue DT, Sagawa K (1987) Contractility-dependent curvilinearity of end-systolic pressurevolume relations. Am J Physiol 252: H1218-H1227
Edes I, Kiss E, Kitada Y, Powers FM, Papp JG, Kranias EG, Solaro RJ (1995) Effects of levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circ Res 77: 107–113
Freeman GL, Little WC, O'Rourke RA (1986) The effect of vasoactive agents on the left ventricular end-systolic pressure-volume relation in closed chest dogs. Circulation 74: 1107–1113
Fujino K, Sperelakis N, Solaro RJ (1988) Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: Comparison with milrinone. Circ Res 63: 911–922
Glower DD, Spratt JA, Snow ND, Kabas JS, Davis JW, Olsen CO, Tyson GS, Sabiston Jr DC, Rankin JS (1985) Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 71: 994–1009
Hagemeijer F, Brand HJ, van Mechelen R (1989) Hemodynamic effects of pimobendan given orally in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 63: 571–576
Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki J, Linden I-B (1995) Cardiac troponin C as a target for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 27: 1859–1866
Haikala H, Linden I-B (1995) Mechanism of action of calcium-sensitizing drugs. J Cardiovasc Pharmacol 26 (Suppl 1): S20-S31
Haikala H, Nissinen E, Etemadzadeh E, Levijoki J, Linden I-B (1995) Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Parmacol 25: 794–801
Hajjar RJ, Gwathmey JK (1991) Calcium-sensitizing inotropic agents in the treatment of heart failure: A critical view. Cardiovasc Drugs Ther 5: 961–965
Harkin CP, Pagel PS, Tessmer JP, Warltier DC (1995) Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs. J Cardiovasc Pharmacol 26: 179–188
Holubarsch C, Hasenfuss G, Heiss WH, Just H (1988) Influence of enoximone and UDCG-115 on coronary hemodynamics in idiopathic dilated cardiomyopathy. Am J Cardiol 62: 104E-107E
Jaquet K, Heilmeyer Jr LMG (1987) Influence of association and of positive inotropic drugs on calcium binding to cardiac troponin C. Biochem Biophys Res Comm 145: 1390–1396
Kass DA, Beyar R, Lankford E, Heard M, Maughan WL, Sagawa K (1989) Influence of contractile state on curvilinearity of in situ end-systolic pressure-volume relations. Circulation 79: 167–178
Kass DA, Grayson R, Marino P (1990) Pressure-volume analysis as a method for quantifying simulataneous drug (amrinone) effects on arterial load and contractile state in vivo. J Am Coll Cardiol 16: 726–732
Kass DA, Yamazaki T, Burkhoff D, Maughan WL, Sagawa K (1986) Determination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique. Circulation 73: 586–595
Katz SD, Kubo SH, Jessup M, Brozena S, Troha JM, Wahl J, Cohn JN, Sonnenblick EH, LeJentel TH (1992) A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure. Am Heart J 123: 95–103
Lilleberg J, Sundberg S, Hayha M, Akila J, Nieminen MS (1994) Haemodynamic dose-efficacy of levosimendan in healthy volunteers. Eur J Clin Pharmacol 47: 267–274
Lilleberg J, Sundberg S, Nieminen MS (1995) Dose-ranging study of a new calcium sensitizer, levosimendan, in patients with left ventricular dysfunction. J Cardiovasc Pharmacol 26 (Suppl 1): S63-S69
Little WC, Cheng C-P (1991) Left ventricular-arterial coupling in conscious dogs. Am J Physiol 261: H70-H76
Little WC, Cheng CP, Mumma M, Igarashi Y, Vinten-Johansen J, Johnston WE (1989) Comparison of measures of left ventricular contractile performance derived from pressure-volume loops in conscious dogs. Circulation 80: 1378–1387
Little WC, Cheng CP, Peterson T, Vinten-Johansen J (1988) Response of the left ventricular end-systolic pressurevolume relation in conscious dogs to a wide range of contractile states. Circulation 78: 736–745
Milnor WR (1975) Arterial impedance as ventricular afterload. Circ Res 36: 565–570
Monrad ES, McKay RG, Baim DS, Colucci WS, Fifer MA, Heller GV, Royal HD, Grossman W (1984) Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. Circulation 70: 1030–1037
Nozawa T, Yasumura Y, Futaki S, Tanaka N, Venishi M, Suga H (1988) Efficiency of energy transfer from pressure-volume area to external mechanical work increases with contractile state and decreases with afterload in the left ventricle of the anesthetized closed-chest dog. Circulation 77: 1116–1124
Pagel PS, Harkin CP, Hettrick DA, Warltier DC (1994) Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs. Anesthesiology 81: 974–987
Pagel PS, Harkin CP, Hettrick DA, Warltier DC (1995) Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs. J Pharmacol Exp Ther 275: 127–135
Piscione F, Jaski BE, Wenting GJ, Serruys PW (1987) Effect of a single oral dose of milrinone on left ventricular diastolic performance in the failing human heart. J Am Coll Cardiol 10: 1294–1302
Pollesello P, Ovaska M, Kaivola J, Tilgmann C, Lundstrom K, Kalkkinen N, Ulmanen I, Nissinen E, Taskinen J (1994) Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. J Biol Chem 269: 28584–28590
Rooke GA, Feigl EO (1982) Work as a correlate of canine left ventricular oxygen consumption, and the problem of catecholamine oxygen wasting. Circ Res 50: 273–286
Schipke JD, Burkhoff D, Kass DA, Alexander Jr J, Schaefer J, Sagawa K (1990) Hemodynamic dependence of myocardial oxygen consumption indexes. Am J Physiol 258: H1281-H1291
Solaro RJ, Fujino K, Sperelakis N (1989) The positive inotropic effect of pimobendan involves stereospecific increases in the calcium sensitivity of cardiac myofilaments. J Cardiovasc Pharmacol 14 (Suppl 2): S7-S12
Stamato TM, Szwarc RS, Benson LN (1995) Measurement of right ventricular volume by conductance catheter in close-chest pigs. Am J Physiol 269 H869-H876
Starling MR (1993) Left ventriculararterial coupling relations in the normal human heart. Am Heart J 125: 1659–1666
Steendijk P, Van der Velde ET, Baan J (1993) Left ventricular stroke volume by single and dual excitation of conductance catheter in dogs. Am J Physiol 264: H2198-H2207
Suga H (1990) Ventricular Energetics. Physiol Rev 70: 247–277
Suga H, Hayashi T, Shirahata M (1981) Ventricular systolic pressure-volume area as a predictor of cardiac oxygen consumption. Am J Physiol 240: H39-H44
Suga H, Sagawa K (1974) Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle. Circ Res 35: 117–126
Sunagawa K, Maughan WL, Burkhoff D, Sagawa K (1983) Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 245: H773-H780
Sunagawa K, Maughan WL, Sagawa K (1985) Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res 56: 586–595
Sundberg S, Lilleberg J, Nieminen MS, Lehtonen L (1995) Hemodynamic and neurohumoral effects of levosimendan, a new calcium sensitizer, at rest and during exercise in healthy men. Am J Cardiol 75: 1061–1066
Szwarc RS, Laurent D, Allegrini PR, Ball HA (1995) Conductance catheter measurement of left ventricular volume: evidence for nonlinearity within the cardiac cycle. Am J Physiol 268: H1490-H1498
Szwarc RS, Mickleborough LL, Mizuno S, Wilson GJ, Liu, P, Mohamed S (1994) Conductance catheter measurements of left ventricular volume in the intact dog: parallel conductance is independent of left ventricular size. Cardiovasc Res 28: 252–258
Thormann J, Kramer W, Schlepper M (1982) Hemodynamic and myocardial energetic changes induced by the new cardiotonic agent, AR-L 115, in patients with coronary artery disease. Am Heart J 104: 1294–1302
Van de Velde ET, Burkhoff D, Steendijk P, Karsdon J, Sagawa K, Baan J (1991) Nonlinearity and load sensitivity of endsystolic pressure-volume relation of canine left ventricle in vivo. Circulation 83: 315–327
van Meel JCA, Zimmermann R, Diederen W, Erdman E, Mrwa U (1988) Increase in calcium sensitivity of cardiac myofibrils contributes to the cardiotonic action of sulmazole. Biochem Pharmacol 37: 213–220
Walter M, Liebens I, Goethals H, Renard M, Dresse A, Bernard R (1988) Pimobendane (UD-CG 115 BS) in the treatment of severe congestive heart failure. An acute haemodynamic crossover and double-blind study with two different doses. Br J Clin Pharmacol 25: 323–329
Author information
Authors and Affiliations
Additional information
This work was supported by US PHS grant HL 54820 and Anesthesiology Research Training Grant GM 08377
Rights and permissions
About this article
Cite this article
Pagel, P.S., Hettrick, D.A. & Warltier, D.C. Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency. Basic Res Cardiol 91, 296–307 (1996). https://doi.org/10.1007/BF00789302
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00789302